(Press-News.org) Philadelphia - Some at-risk patients opted out of comprehensive cancer gene screening when presented with the opportunity to be tested for the presence of genes linked to various cancers, according to a recent study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the Basser Center for BRCA in Penn's Abramson Cancer Center. Concern for uncertainty and potential distress were cited among the most common reasons to refuse testing. The results, published in Genetics in Medicine, were released just weeks ahead of an announcement of the online availability of low-cost genetic testing for breast and ovarian cancer mutations. Authors say the results suggest that patients have varying interest in "gene panels" when they are informed of the potential risks and benefits, reflecting the current need for pre-test counseling when genetic panel testing is considered for at-risk patient populations.
The study found that of the 49 patient participants, all of whom have a family or personal history that puts them at-risk for development breast and other forms of cancer, more than one-third declined multiplex testing. Multiplex testing allows for the simultaneous analysis of alterations in multiple cancer-related genes, and is an alternative to targeted tests that screen for individual forms of cancer. A targeted test might look for inherited mutations in the BRCA1 and BRCA2 genes, for example, which increase the risk of breast, ovarian, and other types of cancer. Some patients also declined the study all together because they were concerned about the uncertainty or distress with testing.
"Traditional targeted genetic tests, such as those for BRCA1/2 mutations, which test for a small number of similar types of genes, can identify beneficial next steps, such as greater screening frequency, or in some cases having the breasts or ovaries removed," said lead author Angela R. Bradbury, MD, an assistant professor of Hematology/Oncology in Penn's Abramson Cancer Center. "But, we don't yet know enough about many of the genes on these panels, so multiplex testing may cause undue anxiety and stress over findings which may turn out to be benign. In addition, patients may take inappropriate risk-reducing or screening interventions based on very limited information."
In the Penn-led study, the most frequent reasons for declining multiplex testing were concern about information overload and concerns about receiving uncertainty regarding the results or medical recommendations. One current criticism of multiplex testing is that it can identify gene variants that may be precursors to or signs of serious forms of cancer for which effective treatments either do not currently exist or are often radical (such as preventive removal of the stomach). In some cases physicians have few remedies to offer except to counsel patients to wait until more knowledge is gained.
In the new study, some patients elected not to participate in the study because they were not interested in testing that could be associated with uncertainty. All of the 49 patients who enrolled received pre-test counseling, which described the advantages (such as early detection) and disadvantages (including increased worry and uncertainty) of the testing. Following the counseling, 16 participants declined multiplex testing or being told their results. Of the 33 who proceeded with multiplex testing, 16 participants tested negative for any cancer-related variants, five tested positive, and 12 were found to have gene variants of uncertain significance (meaning that it is currently unclear if the changes are benign or tied to cancers).
Overall, researchers found that general anxiety decreased significantly after pretest counseling.
Anxiety, depression, and uncertainty, did not significantly increase after learning multiplex test results.
"One note of caution about our findings is that selection bias may be at work since those who thought that they would become worried or anxious excluded themselves from the testing altogether," said the study's senior author Susan M. Domchek, MD, the Basser Professor of Oncology in Penn's Abramson Cancer Center, and executive director of the Basser Center for BRCA. "What these results show, however, is that many patients who receive pre-test counseling, and are therefore better able to understand and interpret their results, do not experience significantly more distress after testing."
The study results were issued just weeks before an announcement about the online availability of low-cost genetic testing for breast and ovarian cancer mutations. "It is important that at this time, this type of genetic testing for cancer be carried out in concert with a genetics professional," said Bradbury. "Our study is the first of its kind to assess how patients react to these types of tests. Given our finding that patients have variable interest in testing and tolerance for uncertainty, it is best for patients to proceed with testing only after understanding the potential risks and limitations. Ongoing larger studies will help us better understand how people respond to these results, particularly when there is some uncertainty regarding the result or the optimal medical management."
INFORMATION:
Other authors from Penn include Laura DiGiovanni, MLA; Jamie Brower, BS; Diana Harris, MBe, PhD; Evelyn M. Stevens, MPH; Kara N. Maxwell, MD, PhD; Abha Kulkarni; Tyler Chavez; Amanda Brandt, MS, CGC; Jessica M. Long, MS, CGC; Jacquelyn Powers, MS, CGC; Jill E. Stopfer, MS, CGC; and Katherine L. Nathanson, MD.
Other co-authors include researchers from the University of Chicago and Fox Chase Cancer Center-Temple University Health System in Philadelphia.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.9 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $409 million awarded in the 2014 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2014, Penn Medicine provided $771 million to benefit our community.
Following lifestyle guidelines about diet, physical activity and maintaining a healthy weight is associated with an improved likelihood of survival when diagnosed with bowel cancer. This is based on the findings of a large study of over 500,000 published in the open access journal BMC Medicine.
Bowel cancer, also called colorectal cancer, is the second most common cancer in men and the third most common cancer in women worldwide, with 55% cases occurring in developed regions such as North America and Western Europe. Survival rates of bowel cancer have wide variations ...
Fans of The Lord of the Rings may disagree, but when it comes to exquisite excavation, the dwarves of Moria have nothing on the mighty fire ants of Georgia Tech. But Dan Goldman and Michael Goodisman aren't fascinated by the aesthetics of fire ant architecture alone. 'I have an interest in animals interacting with complex materials', explains Goldman, who has studied creatures such as sidewinder snakes and sandfish lizards moving through and across sand. With the ants on their doorstep, Goldman and Goodisman were intrigued to learn more about how the insects work together ...
"It took human culture millennia to arrive at a mathematical formulation of non-Euclidean spaces", comments SISSA neuroscientist Alessandro Treves, "but it's very likely that our brains could get there long before. In fact, it's likely that the brain of rodents gets there very naturally every day".
Treves coordinated a study just published in the journal Interface. Euclidean geometry is the kind of geometry we normally study at school, whereas non-Euclidean geometries are all those that reject one or more of Euclid's five postulates. A geometry that unfolds on a curved ...
New developments in personalised and precision medicine (PPM) could offer enormous gains in healthy life expectancy for Americans, but the incentives to develop them are weak, according to Dr Victor Dzau, President of the US Institute of Medicine, and colleagues [1], writing in a Personal View in The Lancet.
PPM tailors medical treatment to the individual characteristics of each patient, according to their susceptibility to a particular illness. But PPM goes beyond just targeting therapies at individuals who are ill; it includes the ability to identify those at highest ...
PROVIDENCE, R.I. [Brown University] -- Surveys of loved ones who lost elderly relatives show that the perception of the quality of care for the dying in the United States has worsened over the last decade. For all the health care industry has done to try to make progress, huge gaps remain between how care is delivered and what patients and their loved ones want, reports a new study in the Journal of Palliative Medicine.
"People are less satisfied with care at the close of life, and I think it's now urgent for us to start thinking about what interventions we can do to ...
DALLAS, May 6, 2015 -- People with hemorrhagic strokes (brain bleeds) are more likely to survive if they are treated at a comprehensive stroke center, according to research published in the Journal of the American Heart Association.
Hemorrhagic strokes, which account for about 13 percent of all strokes, are caused when a weakened blood vessel in the brain ruptures and bleeds in the surrounding brain. Comprehensive stroke centers typically have the specialists and trained personnel to deal with patients with these ruptures or other types of bleeding in the brain. They ...
Insurance coverage has increased across all types of insurance since the major provisions of the federal Affordable Care Act took effect, with a total of 16.9 million people becoming newly enrolled through February 2015, according to a new RAND Corporation study.
Researchers estimate that from September 2013 to February 2015, 22.8 million Americans became newly insured and 5.9 million lost coverage, for a net of 16.9 million newly insured Americans.
Among those newly gaining coverage, 9.6 million people enrolled in employer-sponsored health plans, followed by Medicaid ...
Psychologists are to improve online health information on lung cancer after research showed that family members are more likely to search online to encourage loved ones to seek help.
This is one of the outcomes from research by PhD student Julia Mueller based in the School of Nursing, Midwifery and Social Work at The University of Manchester (part of the Manchester Cancer Research Centre) who will present her study today, Thursday 7 May 2015, at the Annual Conference of the British Psychology Society being held in Liverpool.
Julia Mueller said: "People displaying ...
The ulcer-causing bacterium Helicobacter pylori can directly interact with stomach stem cells, causing the cells to divide more rapidly, according to a new study by researchers at the Stanford University School of Medicine.
The increased cell division was observed in mice, but the findings could explain why H. pylori is a risk factor for gastric cancer in humans, the researchers said.
They used 3-D microscopy to identified colonies of the bacteria deep within human stomach glands, where stem cells and precursor cells that replenish the stomach's lining reside.
One ...
MADISON, Wis. -- The suspicion that the federal Affordable Care Act reduces options for patients to choose their health care providers proves to be true, according to a new study co-authored by David Weimer, a professor with the La Follette School of Public Affairs at the University of Wisconsin-Madison. However, the quality of hospitals in insurance exchange networks was as good or better than those in commercial insurance networks.
The study, just published in the May issue of the journal Health Affairs, compared the hospital networks available to California consumers ...
